AD

22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings

Logo Benzinga
Benzinga
By Globe Newswire

BUFFALO, N.Y., May 27, 2024 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. XXII, a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced that James A. Mish, Chief Executive Officer, and Richard Fitzgerald, Chief Financial Officer, will host meetings with investors at two upcoming investor conference events in June 2022.

AD
AD

Institutional investors participating in the conference can request a meeting with management through their institutional representative, or by contacting 22nd Century Group's investor relations team via [email protected].

About 22nd Century Group, Inc.

22nd Century Group, Inc. (Nasdaq:XXII) is a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, The Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of theFDA's Comprehensive Planto address the widespread death and disease caused by smoking. The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021, now in a pilot marketing program in the United States. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.

Continue read on benzinga.com

AD
Logo Benzinga
Provides Transformational Platform to Rapidly Grow Hemp/Cannabis Franchise Transaction Immediately Accretive and Will Double Company's Total Revenue Adds...

Logo Benzinga
Launched VLN®Pilot Program in Chicago with Circle K as First Retail Trade Partner Began VLN®Shipments to South Korea for First International Launch FDA's...

Logo Benzinga
BUFFALO, N.Y., May 23, 2024 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. XXII, a leading agricultural biotechnology company focused on tobacco harm...

Logo Benzinga
22nd Century Group, Inc. XXII reported results for the first quarter ended March 31, 2022.. The company will host a live audio webcast on May 5, at 10:00...

Logo Benzinga
Mind Medicine Names New CEO Mind Medicine Inc. MNMD MMED has hired Schond L. Greenway to oversee its finance department. Greenway comes to MindMed with over...

Logo Benzinga
22nd Century Group, Inc. XXII announced the acquisition of privately held GVB Biopharma. GVB - a contract development and manufacturing organization -...

Logo Nasdaq
MarketsBy Zacks 5 May
22nd Century Group (XXII) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of...

Logo Benzinga
LAS VEGAS and VANCOUVER, British Columbia, May 13, 2024 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. TAAT TOBAF 2TP (the Company or TAAT®) is pleased...

Logo The Business Journals
The acquisition of GVB BioPharma will boost the research efforts of the Clarence biotech company known for developing a low-nicotine cigarette in the hemp...

Logo Benzinga
Philip Morris International Inc. (PMI) PM today confirmed, in response to recent market speculation, that discussions are ongoing between PMI and Swedish...

Logo Benzinga
Regulatory News: Philip Morris International Inc. (PMI) PM will host a live video webcast of the company's remarks and question-and-answer session by...

Logo Benzinga
RumbleOn, Inc. RMBL (the Company or RumbleOn), the nation's first technology-based omnichannel powersports platform, announced today that it will participate...

Logo PR Newswire
LOS ANGELES, May 23, 2024 /PRNewswire/ -- Cadiz Inc. ("the Company", NASDAQ: CDZI/CDZIP), a California business dedicated to sustainable water and...

Logo Benzinga
EMERYVILLE, Calif., May 23, 2024 /PRNewswire/ -- Amyris, Inc. AMRS, a leading synthetic biotechnology company accelerating the world's transition to...

Logo PR Newswire
AUSTIN, Texas, May 16, 2024 /PRNewswire/ -- Aviat Networks, Inc. (NASDAQ: AVNW), the leading expert in wireless transport solutions, today announced its...

Logo GlobeNewswire
DELAWARE, Ohio, May 26, 2024 (GLOBE NEWSWIRE) -- Franchise Group, Inc. (NASDAQ: FRG) (Franchise Group or the Company) today announced that it will...

Logo Benzinga
GAITHERSBURG, Md., May 4, 2024 /PRNewswire/ -- Novavax, Inc. NVAX, a biotechnology company dedicated to developing and commercializing next-generation...

Logo Benzinga
ROCKVILLE, Md., May 4, 2024 /PRNewswire/ -- REGENXBIO Inc. RGNX today announced it will participate in the following upcoming investor conferences: Bank of...

Logo Benzinga
SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, May 19, 2024 /PRNewswire/ -- Gracell Biotechnologies Inc. GRCL (Gracell), a global clinical-stage...

Logo Benzinga
SALT LAKE CITY, May 2, 2024 /PRNewswire/ -- Recursion RXRX, the clinical-stage biotechnology company industrializing drug discovery by decoding biology,...